Sign in
CompletedNo phase

Association of Arterio-Venous Oxygen and Carbon Dioxide Gradients With Tissue Hypoperfusion and Mortality in Sepsis

Key facts

Who runs it
Gaziosmanpasa Research and Education Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
88 people enrolled
Started
1 Mar 2025
Ended
13 Jan 2026
Type of study
Observational
Record updated
17 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult patients aged 18 years or older
  • Diagnosis of sepsis
  • Admission to the intensive care unit
  • Intubated and receiving invasive mechanical ventilation
  • Presence of a central venous catheter

Who cannot take part

  • Patients receiving oxygen therapy via face mask or nasal cannula
  • Patients treated with non-invasive mechanical ventilation
  • Patients younger than 18 years
  • Patients in whom a central venous catheter cannot be placed

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In patients with sepsis who are treated in the intensive care unit under invasive mechanical ventilation, the combined evaluation of ScvO₂ and PcvCO₂ may provide a comprehensive insight into tissue oxygenation and metabolic stress, allowing a more precise hemodynamic assessment in critically ill patients. The aim of this study is to evaluate the monitoring of ScvO₂, PcvCO₂, and EtCO₂ in intensive care patients in order to predict hemodynamic instability, 28-day mortality, and length of ICU stay, as well as to investigate their effects on cardiac output, tissue oxygenation, and hypoperfusion.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 July 2026